{
  "ticker": "BMRN",
  "company_name": "BioMarin Pharmaceutical",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03392974",
      "title": "Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hemophilia A",
      "start_date": "2018-03-14",
      "completion_date": "2023-06-05",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT01609062",
      "title": "Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Mucopolysaccharidosis IVA, Morquio A Syndrome, MPS IVA",
      "start_date": "2012-04",
      "completion_date": "2014-11",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT04055051",
      "title": "ATHN 11: Liver Transplantation Outcomes Study",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Hemophilia A and B, Liver Transplantation",
      "start_date": "2020-06-18",
      "completion_date": "2022-12-01",
      "enrollment": 0,
      "sponsor": "American Thrombosis and Hemostasis Network"
    },
    {
      "nct_id": "NCT03792451",
      "title": "Nutrition Status of Adults Treated With Pegvaliase",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Phenylketonurias",
      "start_date": "2019-01-17",
      "completion_date": "2020-12-31",
      "enrollment": 0,
      "sponsor": "Boston Children's Hospital"
    },
    {
      "nct_id": "NCT01966029",
      "title": "BMN 110 Phase 3B in Australian Patients",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Mucopolysaccharidosis IVA (Morquio A Syndrome)",
      "start_date": "2013-07",
      "completion_date": "2016-12",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT04452513",
      "title": "A Prospective Clinical Study of Phenylketonuria (PKU)",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Phenylketonurias",
      "start_date": "2019-10-11",
      "completion_date": "2022-06-02",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT00484991",
      "title": "Sapropterin Expanded Access Program",
      "status": "APPROVED_FOR_MARKETING",
      "phase": "",
      "condition": "Phenylketonuria",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT04323098",
      "title": "Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hemophilia A",
      "start_date": "2020-12-08",
      "completion_date": "2025-05-08",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT01819727",
      "title": "An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Phenylketonuria",
      "start_date": "2013-05",
      "completion_date": "2015-11-25",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT01924845",
      "title": "BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Late-onset Pompe Disease",
      "start_date": "2014-04",
      "completion_date": "2016-09-12",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE3": 15,
      "PHASE2": 13,
      "": 12,
      "PHASE1, PHASE2": 3,
      "NA": 3,
      "PHASE1": 3,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 28,
      "TERMINATED": 10,
      "APPROVED_FOR_MARKETING": 1,
      "ACTIVE_NOT_RECRUITING": 4,
      "RECRUITING": 4,
      "ENROLLING_BY_INVITATION": 1,
      "WITHDRAWN": 2
    },
    "active_trials": 9,
    "completed_trials": 28,
    "conditions": [
      "Achondroplasia",
      "Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer",
      "Autistic Disorder",
      "Behavioral Manifestations of Lesch-Nyhan Disease",
      "Duchenne Muscular Dystrophy",
      "Endothelial Dysfunction",
      "Heart Failure, Cardiovascular Disease",
      "Hemophilia A",
      "Hemophilia A and B, Liver Transplantation",
      "Hemophilia A, Gene Therapy, Clotting Disorders, Blood Disorder",
      "Hyperphenylalaninemia, Phenylketonuria",
      "Hypochondroplasia",
      "Idiopathic Short Stature",
      "Isolated Systolic Hypertension, Endothelial Dysfunction",
      "Kidney Disease, Albuminuria",
      "Late-onset Pompe Disease",
      "Mucopolysaccharidosis IV A, Morquio A Syndrome, MPS IVA",
      "Mucopolysaccharidosis IVA (Morquio A Syndrome)",
      "Mucopolysaccharidosis IVA, Morquio A Syndrome, MPS IVA",
      "Mucopolysaccharidosis Type IVA",
      "Mucopolysaccharidosis VI",
      "Muscular Dystrophies",
      "Phenylketonuria",
      "Phenylketonuria (PKU)",
      "Phenylketonurias",
      "Sickle Cell Disease",
      "Solid Tumors, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma, Nonsmall Cell Lung Cancer"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:03:08.287200",
    "search_query": "BioMarin Pharmaceutical",
    "url": "https://clinicaltrials.gov/search?term=BioMarin+Pharmaceutical"
  }
}